Ad
related to: atra
Search results
After Plunging 65.7% in 4 Weeks, Here's Why the Trend Might Reverse for Atara Biotherapeutics (ATRA)
Zacks via Yahoo Finance· 2 years agoAtara Biotherapeutics (ATRA) has become technically an oversold stock now, which implies exhaustion...
Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study
Zacks via Yahoo Finance· 9 months agoAtara (ATRA) rises 11% on an update regarding the regulatory pathway for the company's lead product...
Atara Biotherapeutics Inc (ATRA) Announces Q3 2023 Financial Results and Expanded Global Partnership
GuruFocus.com via Yahoo Finance· 7 months agoAtara Biotherapeutics Inc (NASDAQ:ATRA) announced its Q3 2023 financial results and an expanded...
After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have...
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAtara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -5.13% and 2.13%,...
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Analysts Are More Bearish Than They Used To Be
Simply Wall St. via Yahoo Finance· 1 year agoToday is shaping up negative for Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shareholders, with the...
Atara Biotherapeutics (NASDAQ:ATRA) shareholders are up 17% this past week, but still in the red...
Simply Wall St. via Yahoo Finance· 2 years agoThis week we saw the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) share price climb by 17%. But only...
The Market Doesn't Like What It Sees From Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Revenues Yet
Simply Wall St. via Yahoo Finance· 1 year agoAtara Biotherapeutics, Inc.'s (NASDAQ:ATRA) price-to-sales (or "P/S") ratio of 4.4x might make it...
Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why
Zacks via Yahoo Finance· 6 months agoAtara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapies...
Mizuho On Atara Biotherapeutics - Distinguish Between Small Numbers And Science Failure
Benzinga via Yahoo Finance· 2 years agoAtara Biotherapeutics Inc (NASDAQ: ATRA) issued its anticipated interim analysis communication for...